NIFTY
90.20  0.95%
 9580.30
S&P BSE SENSEX
223.51  0.69%
 32424.1
Aurobindo Pharma Ltd.
NSE : AUROPHARMA BSE : 524804 ISIN code : INE406A01037
on 29-May-2020
NSE
31.7    4.44%
Rs. 745.65
 
Days Low
Rs. 710
Days High
Rs. 750.5

Open Rs. 710
 
52 week Low
Rs. 281.15
52 week High
Rs.750.5
 
 
Bid :                 0.00 (0)
Offer :        0.00 (0)
BSE
Rs.745.05
31.2    4.37%
on 29-May-2020
BSE
31.2    4.37%
Rs. 745.05
 
Days Low
Rs. 711.2
Days High
Rs. 750.35

Open Rs. 715.9
 
52 week Low
Rs. 288.85
52 week High
Rs.750.35
 
 
Bid :                 0.00 (0)
Offer :        0.00 (0)
NSE
Rs.745.65
31.7    4.44%
 
 
Last Price (Rs.)  745.05 Value  154833819.00
Net Change (Rs.)  31.20 Best Buy  0.00
Volume  210485 Best Sell  0.00
Prev.Close (Rs.)  713.85 Best Quantity  0
Open (Rs.)  710.00 Sell Quantity  0
High (Rs.)  750.50 52-Week High (Rs.)  750.50
Low (Rs.)  710.00 52-Week Low (Rs.)  281.15
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  436553.56
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital585.90 585.90 585.90 
Share Capital585.90 585.90 585.90 
Share Capital585.90 585.90 585.90 
Share Capital585.90 585.90 585.90 
Share Capital585.90 585.90 585.90 
Currents Investments0.20 0.20 0.20 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 475.45 1140764 101.68 139.69 0.21
Dr. Reddys Lab 4073.80 676952 914.23 52.94 0.61
Divis Lab 2395.75 635996 280.36 47.72 0.67
Cipla 647.60 522121 215.85 27.63 0.46
Biocon 354.70 425640 62.81 43.19 0.28
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Dec 2019Sep 2019Jun 2019
Net Sales33456.7032216.6030788.30
Operating Profit6891.606648.505805.50
PBDT6678.506399.905486.00
Net Profit4190.703981.303305.00
More> 
 
Company News
5/4/2020 12:00:00 AM
Aurobindo Pharma gets USFDA’s nod for Flucytosine Capsules
5/4/2020 12:00:00 AM
Aurobindo Pharma zooms on getting USFDA’s nod for Flucytosine Capsules
4/29/2020 12:00:00 AM
Aurobindo Pharma informs about compliance certificate
More>
 
Ratios
   Earnings Per Share (Rs)26.11 
   Book NAV/Share(Rs)193.73 
   PAT Margin (%)12.48 
   Asset Turnover(x)0.72 
   PER(x)30.10 
   Yield(%)0.32 
   EV/Core EBITDA(x)19.36 
   M Cap / Sales3.76 
   Net Sales Growth(%)19.36 
   PAT Growth(%)-15.61 
   Total Debt/Equity(x)0.40 
   Current Ratio(x)1.55 
   Quick Ratio(x)0.96 
   Total Debt/Mcap(x)0.10 
More>